Company Filing History:
Years Active: 2018-2022
Title: Knut Woltjen: Innovator in Cancer Therapeutics and Stem Cell Research
Introduction
Knut Woltjen is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the fields of cancer therapeutics and stem cell research. With a total of 2 patents, his work focuses on innovative methods that have the potential to transform medical treatments.
Latest Patents
Woltjen's latest patents include a method for screening for cancer therapeutic agents. This invention aims to provide a method of screening for a therapeutic drug for cancer as a molecular-targeted drug. It targets specific proteins from a number of candidate target proteins without the need to identify the true target protein. The method involves expressing an exogenous cell regulatory factor in a target cancer cell, confirming changes in the cancer cell, and selecting the test substance as a therapeutic drug when the change in the cancer cell is increased under contact with the test substance compared to no contact.
Another significant patent is a method of inducing differentiation from pluripotent stem cells to skeletal muscle cells. This invention provides a method for producing a skeletal muscle cell from a pluripotent stem cell. It includes a step of expressing one or more exogenous factors selected from MyoD, Myf5, and nucleic acids encoding them on a pluripotent stem cell.
Career Highlights
Knut Woltjen has worked with prestigious institutions such as the University of Tokyo and Kyoto University. His research has been instrumental in advancing the understanding of cancer treatment and regenerative medicine.
Collaborations
Woltjen has collaborated with notable colleagues, including Yasuhiro Yamada and Katsunori Semi. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Knut Woltjen's contributions to cancer therapeutics and stem cell research highlight his role as a leading inventor in these fields. His innovative methods have the potential to significantly impact medical science and improve patient outcomes.